Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
CLINUVEL posts record half-year revenue as expansion strategy accelerates
February 26, 2026 - - Latest News -
EU backs Vaxxas-led consortium with up to $250m to advance next-generation influenza vaccines
February 26, 2026 - - Latest News -
Imugene sharpens focus on Azer-Cel as costs fall and clinical progress builds
February 25, 2026 - - Latest News -
Neurizon advances ALS drug program as funding, trials and global partnerships gain momentum
February 25, 2026 - - Latest News -
Acrux returns to profit as product launches and strategic reset drive revenue growth
February 25, 2026 - - Latest News -
Immutep strengthens focus on late-stage immunotherapy trial as pipeline momentum builds
February 25, 2026 - - Latest News -
Blood test discovery may help predict head and neck cancer relapse risk
February 25, 2026 - - Latest News